Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Products
  • Abirtega (abiraterone acetate) USP
Where it was sold

Nationwide within the United States

Nationwide

Units affected
2136 bottles
About this recall
Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.